RACHEL ASQUITH: Open Payments
NPI 1952786022 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,911 in 85 payments from 16 companies in 2025. Trend: 2023 $1,121 · 2024 $1,636 · 2025 $2,911
Food & beverage: $1,786Consulting: $1,125
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $1,328 |
| GENZYME CORPORATION | 8 | $276 |
| Novartis Pharmaceuticals Corporation | 15 | $199 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $197 |
| UCB, Inc. | 7 | $187 |
| Regeneron Healthcare Solutions, Inc. | 2 | $145 |
| Galderma Laboratories, L.P. | 10 | $138 |
| Lilly USA, LLC | 11 | $133 |
| LEO Pharma Inc. | 4 | $85 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
Products named: TREMFYA, DUPIXENT, ILUMYA, Bimzelx, COSENTYX, NEMLUVIO, LIBTAYO, TALTZ.
Industry payments across TN — which companies pay providers there.
